Login

Prof. Rob Phillips, CEO of Uscom 00:00:00

Share On Facebook Share On Twitter

Prof. Rob Phillips, CEO of Uscom

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Brief description by the CEO of Awardit AB | Erik Grohman, CEO, Awardit AB (publ) AWRD:STO
00:10:00
Xylem's Patrick Decker and Evoqua's Ron Keating, CEOs of water technology firms, discuss the implications of a $7.5 billion deal.
00:10:00
Overview of Yellowcake plc and the Uranium Market.
00:10:00
Gold Terra Resource Corp Presentation at Virtual Investor Conference
00:10:00
Bitfarms Talks Bitcoin and Ethereum Mining, Recent Mining Results and Expansion Plan in Argentina | Geoff Morphy, CEO, Bitfarms LtdBITF:TOR
00:10:00
Andreas Gerward, CEO of Stayble Therapeutics, Shares Expertise on Clinical Trials in Eastern Europe and Industry Challenges | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Vulcan Energy Gears Up for Key Milestones in Zero-Carbon Battery Production | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:00:00
Innovation to Impact: Minimally Invasive Innovation - Brennan Boettcher, Orthopedic Surgon, Mayo clinic
00:10:00
"Unlock the future of PetVivo Holdings, Inc. (NASDAQ) with Mr. John Lai, the driving force behind the company's vision, as he illuminates groundbreaking strategies and insights in this exclusive interview."|Mr. Lai has been a director and senior executive
00:10:00
Thriving in the Evolving Fintech Landscape: The Importance of Continuous Growth|Andrew Endicott,Founding Partner,Gilgamesh Ventures
00:10:00
Unlocking the therapeutic potential of rare cannabinoids|Eric A. Adams,CEO,InMed Pharmaceuticals Inc
00:10:00
ESG Reflections & Future Outlook | Susan H. Mac Cormac - Partner of morrison foerster

© 2026 Nehu